Integrating ctDNA MRD Testing to Guide NSCLC Management: Precision Oncology Breakthrough vs Early Clinical Evidence
Moderator: Natasha Leighl, MD, FRCPC, FASCO
Lung Site Lead, Medical Oncology
Princess Margaret Cancer Centre
Precision Oncology Breakthrough: Edward Garon, MD, MS
Professor
University of California, Los Angeles
Early Clinical Evidence: Luis Raez, MD, FASCO
Chief Scientific Officer & Medical Director
Memorial Cancer Institute/Florida Atlantic University
